Fig. 2From: Combination therapy of brain radiotherapy and EGFR-TKIs is more effective than TKIs alone for EGFR-mutant lung adenocarcinoma patients with asymptomatic brain metastasisCombination therapy group had similar PFS and OS, but better iPFS than only TKIs therapy group in LAC patients with EGFR-mutant and BMBack to article page
